Bayer Corporation Emerges as a Global Leader in the Industry

Strategic Insights -

Bayer Corporation, formerly known as Miles Inc., marked a significant milestone in its history by adopting the globally recognized name Bayer. This move allows the company to leverage its existing equity and assure customers worldwide of consistently high-quality products. Celebrations were held at over 50 sites across the U.S. and Canada to commemorate the name change, which followed the acquisition of Sterling Winthrop's North American OTC drug business in 1994. The acquisition also returned the rights to the Bayer Cross trademark and name in the U.S., Canada, and the Caribbean to the German-based parent company, Bayer AG.

Key Takeaways:

  • Bayer Corporation is a $26.8 billion research-based company with major businesses in health care and life sciences, chemicals, and imaging technologies.
  • The company has 146,700 employees and operations in 140 countries.
  • The name change follows the 1994 acquisition of Sterling Winthrop's North American OTC drug business.
  • The acquisition returned the rights to the Bayer Cross trademark and name in the U.S., Canada, and the Caribbean to Bayer AG.
  • Bayer Corporation employs 24,000 people and had sales of $7.1 billion in 1994.
  • The company manufactures a wide range of products, including Bayer Aspirin, pharmaceuticals, biological products, diagnostic equipment, crop protection products, animal health products, plastics, polyurethanes, and coating raw materials.

Statistics:

  • $26.8 billion: Bayer Corporation's annual revenue.
  • 146,700: Number of employees worldwide.
  • 140: Number of countries where Bayer Corporation operates.
  • $7.1 billion: Bayer Corporation's sales in 1994.
  • 24,000: Number of employees in the U.S. subsidiary of Bayer Corporation.
  • Over 50: Number of sites that held celebrations to commemorate the new name.

Sources:

  • PRNewswire, April 3, 1995
  • Bayer Corporation press release, April 3, 1995